Girija Bhoite, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 3 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
15 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bhoite’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Drugs they prescribed that Part D paid
$10,484
Pharmacies billed $10,484 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
168 generic and 14 brand-name prescriptions · $10,484 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dofetilide | 12 | $455 | $38 |
| Atorvastatin | 28 | $162 | $6 |
| Isosorbide Mononitrate Er | 15 | $159 | $11 |
| Amlodipine Besylate | 29 | $123 | $4 |
| Carvedilol | 17 | $90 | $5 |
See all 6 drugs
| Dofetilide | 12 | $455 | $38 |
| Atorvastatin | 28 | $162 | $6 |
| Isosorbide Mononitrate Er | 15 | $159 | $11 |
| Amlodipine Besylate | 29 | $123 | $4 |
| Carvedilol | 17 | $90 | $5 |
| Lisinopril | 12 | $69 | $6 |
Year by year
| 2024 | 182 | 32 | None | 8% | $10,484 |
| 2023 | 142 | 29 | None | None | $9,165 |
| 2022 | 180 | 45 | None | 18% | $26,607 |
| 2021 | 64 | 15 | 0% (0) | 22% | $5,302 |
| 2020 | 61 | 15 | 0% (0) | 51% | $165,276 |
| 2019 | 66 | 22 | None | None | $4,919 |
| 2018 | 167 | 45 | None | None | $9,981 |
| 2017 | 293 | 67 | 4% (12) | None | $16,986 |
| 2016 | 192 | 37 | 8% (15) | None | $9,528 |
| 2015 | 83 | 23 | None | None | $3,885 |
| 2014 | 18 | None | None | None | $903 |
| 2013 | 205 | 44 | None | None | $9,423 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Isosorbide Mononitrate Er | 22 | $361 | $16 |
| Amlodipine Besylate | 17 | $113 | $7 |
| Carvedilol | 14 | $95 | $7 |
| Atorvastatin | 17 | $90 | $5 |
| Furosemide | 11 | $39 | $4 |
2022: 4 drugs
| Isosorbide Mononitrate Er | 18 | $445 | $25 |
| Metoprolol | 22 | $245 | $11 |
| Carvedilol | 14 | $145 | $10 |
| Furosemide | 13 | $62 | $5 |
2020: 1 drug
| Orenitram Er | 17 | $158,957 | $9,350 |
2018: 2 drugs
| Isosorbide Mononitrate Er | 12 | $219 | $18 |
| Furosemide | 18 | $73 | $4 |
2017: 6 drugs
| Potassium Chloride | 12 | $426 | $35 |
| Torsemide | 17 | $253 | $15 |
| Hydralazine | 12 | $216 | $18 |
| Warfarin | 11 | $83 | $8 |
| Lisinopril | 14 | $57 | $4 |
| Furosemide | 17 | $50 | $3 |
2016: 1 drug
| Warfarin | 25 | $160 | $6 |
2013: 3 drugs
| Metformin | 15 | $149 | $10 |
| Pravastatin | 12 | $133 | $11 |
| Lisinopril | 14 | $72 | $5 |
Money from drug and device companies
$257 in 2025
| 2025 | 4 | 5 | None | $257 |
| 2024 | 5 | 8 | None | $169 |
| 2023 | 9 | 13 | None | $538 |
| 2022 | 7 | 12 | None | $569 |
| 2021 | 5 | 13 | None | $455 |
| 2020 | 1 | 3 | None | $38 |
| 2019 | 1 | 2 | None | $53 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Mitraclip | $137 | 1 payment
|
| Abiomed | None | $55 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $36 | 1 payment
|
| Edwards Lifesciences | Pascal | $29 | 1 payment
|
See all 5 published payments
| Abiomed | Meals · 2025-07-07 | None | $27 |
| Abiomed | Meals · 2025-06-02 | None | $28 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-05-05 | Lifevest | $36 |
| Abbott Laboratories | Meals · 2025-02-24 | Mitraclip | $137 |
| Edwards Lifesciences | Meals · 2025-01-20 | Pascal | $29 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $169
| Abiomed | Impella | $79 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $37 | 2 payments
|
| Amgen | Repatha | $21 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $18 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $13 | 1 payment
|
2023: $538
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $222 | 4 payments
|
| Abiomed | Impella | $147 | 1 payment
|
| Boston Scientific | Avvigo Guidance System | $44 | 1 payment
|
| Merck Sharp & Dohme | Verquvo | $29 | 2 payments
|
| Actelion Pharmaceuticals US | Uptravi | $26 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $22 | 1 payment
|
| Pfizer | Vyndaqel | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $15 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $14 | 1 payment
|
2022: $569
| Sanofi-Aventis U.S. | None | $125 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $113 | 3 payments
|
| Actelion Pharmaceuticals US | Uptravi | $109 | 1 payment
|
| Itamar Medical | Watchpat | $86 | 1 payment
|
| Medtronic | Cobalt Dr Mri Surescan | $71 | 2 payments
|
| Merck Sharp & Dohme | Verquvo | $53 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $12 | 1 payment
|
2021: $455
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $149 | 9 payments
|
| Cardiva Medical | Cardiva Vascade Mvp Vvcs 6-12f | $119 | 1 payment
|
| Abbott Laboratories | Confirm Rx | $92 | 1 payment
|
| Boston Scientific | General Pain Management | $83 | 1 payment
|
| Pfizer | Eliquis | $13 | 1 payment
|
2020: $38
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $38 | 3 payments
|
2019: $53
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $53 | 2 payments
|
Professional record
- NPI
- 1811202757
- Licence
- MD D76550
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Hospitalist (208M00000X); Internal medicine (207R00000X)
- Mailing address
- 2000 15th St N Ste 600, Arlington, VA, 22201
- NPI first listed
- 2010-08-16
- NPI last updated
- 2017-11-20
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1960 Ogden St, Denver, CO, 80218